[1] Stutchfield BM,Forbes SJ,Wigmore SJ,et al.Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl. 2010;16:827-836.[2] Manuelpillai U,Moodley Y,Borlongan CV,et al. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta. 2011;32: S320-325.[3] Lysy PA,Campard D,Smets F,et al .Stem cells for liver tissue repair: Current knowledge and perspectives. World J Gastroenterol. 2008; 14:864-875.[4] Laurson J,Selden C,Hodgson HJ,et al. Hepatocyte progenitors in man and in rodents multiple pathways, multiple candidates. Int J Exp Pathol. 2005;86:1-18.[5] Couto BG,Goldenberg RC,Fonseca LM,et al. Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver Int. 2011;31:391-400.[6] Moriya K,Yoshikawa M,Ouji Y,et al. Embryonicstem cells reduce liver fibrosis in CCl4-treated mice. J Exp Pathol. 2008; 89(6):401-409.[7] Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl. 2010;16: 118-129.[8] Basma H,Soto-Gutierrez A,Yannam GR,et al.Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology.2009; 136(3):990-999.[9] Xu YQ. Liu ZC. Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches. Stem Cell Rev. 2008;4(2):101-112.[10] Houlihan DD,Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology. 2008;135(2):438-445.[11] Ilancheran S,Michalska A,Peh G,et al. Stem cells derived from human fetal membranes display multilineage differentiation potential. BiolReprod. 2007;77(3):577-588. [12] Parolini O,Alviano F,Bagnara GP,et al. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international Workshop on Placenta Derived Stem Cells.Stem Cells. 2008;26:300-311.[13] Tamagawa T,Ishiwata I,Saito S,et al. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro. Hum Cell. 2004;17:125-130.[14] Evangelista M,Soncini M,Parolini O,et al Placenta derived stem cells: New hope for cell therapy? Cytotechnology. 2008; 58:33-42.[15] Takashima S. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct.2004;29(3):73-84.[16] Miki T,Lehmann T,Cai H,et al.Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005; 23(10):1549-1559.[17] Sakuragawa N,Tohyama J,Yamamoto H,et al. Immunostaining of human amniotic epithelial cells: possible use as a transgene carrier in gene therapy for inborn errors of metabolism. Cell Transplant. 1995;4(3):343-346.[18] Diaz-Prado S. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J Cell Biochem. 2010;111(4):846-857.[19] 罗宏武,黄湘俊,黄飞舟,等.人羊膜上皮细胞有向肝细胞样细胞分化的特性[J]. 中华肝脏病杂志,2011,19(8):683-684.[20] Eichna DM,Brown KS,Breen A,et al. Mucormycosis: A rare but serious infection. Clin. J Oncol Nurs. 2008; 12:108-112.[21] Li H, Niederkorn JY, Neelam S, et al.Immunosuppressive Factors in Amniotic Epithelial Cells. IOVS. 2005;46:900-907[22] Tseng SC,Meller D,Anderson DF,et al. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane for treating corneal diseases with total limbal stem cell defi ciency. AdvExp Med Biol. 2002;506(Pt B): 1323-1334.[23] Liu YH, Vaghjiani V, Tee JY, et al. Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis .PLoS One.2012; 7(4): 357-358.[24] Sakuragawa N,Misawa H,Ohsugi K,et al. Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease. Neurosci Lett. 1997;232(1): 53-56.[25] Diaz-PradoS. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J Cell Biochem.2010;111(4): 846-857.[26] Manuelpillai U, Lourensz D, Vaghjiani V,et al.Human Amniotic Epithelial Cell Transplantation Induces Markers of Alternative Macrophage Activation and Reduces Established Hepatic Fibrosis.PLoS One. 2012; 7(6): e38631.[27] Manuelpillai U,Tchongue J,Lourensz D,et al. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl4-treated mice. Cell Transplantation. 2010;19: 1157-1168.[28] Luciana B,Cargnoni A,ResselL,et al. Amniotic Membrane Application Reduces Liver Fibrosis in a Bile Duct Ligation Rat Model. Cell Transplantation. 2011;20:441-453. [29] Dabeva MD,Petkov PM,Sandhu J,et al. Proliferation and differentiation of fetal liver epithelial progenitor cells after transplantation into adult rat liver. Am J Pathol. 2000;156(6): 2017-2031.[30] Kollet O,Shivtiel S,Chen YQ,et al. HGF. SDF-1.and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest. 2003;112:160-169. |